Vascular Biogenics Ltd. (VBLT)
(Delayed Data from NSDQ)
$1.28 USD
+0.01 (0.79%)
Updated May 3, 2019 03:59 PM ET
After-Market: $1.28 (%) 5:22 PM ET
NA Value
NA Growth NA Momentum NA VGMBrokerage Reports
0 items in cart
Notable Labs, Ltd. [VBLT]
Reports for Purchase
Showing records 1 - 20 ( 143 total )
Company: Notable Labs, Ltd.
Industry: Medical - Biomedical and Genetics
Company: Notable Labs, Ltd.
Industry: Medical - Biomedical and Genetics
Evaluating Strategic Options While Developing VB-601; Reiterate Neutral
Provider: H.C. Wainwright & Co., Inc.
Analyst: RAMAKANTH S
Company: Notable Labs, Ltd.
Industry: Medical - Biomedical and Genetics
Company: Notable Labs, Ltd.
Industry: Medical - Biomedical and Genetics
Company: Notable Labs, Ltd.
Industry: Medical - Biomedical and Genetics
Company: Notable Labs, Ltd.
Industry: Medical - Biomedical and Genetics
Company: Notable Labs, Ltd.
Industry: Medical - Biomedical and Genetics
Company: Notable Labs, Ltd.
Industry: Medical - Biomedical and Genetics
Company: Notable Labs, Ltd.
Industry: Medical - Biomedical and Genetics
OVAL Trial Fails, Determining VB-111 Next Steps in mCRC and rGBM
Provider: Roth Capital Partners, Inc.
Analyst: ASCHOFF J
Company: Notable Labs, Ltd.
Industry: Medical - Biomedical and Genetics
All Eyes on OVAL Top-Line Readout; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: RAMAKANTH S
Company: Notable Labs, Ltd.
Industry: Medical - Biomedical and Genetics
1Q22: Transformational 2022 Brings OVAL, rGBM, & mCRC Data; Cash Thru 2023
Provider: Roth Capital Partners, Inc.
Analyst: ASCHOFF J
Company: Notable Labs, Ltd.
Industry: Medical - Biomedical and Genetics
Company: Notable Labs, Ltd.
Industry: Medical - Biomedical and Genetics
Additional Molecular Details Describing VB-601 Mechanism of Action
Provider: Roth Capital Partners, Inc.
Analyst: ASCHOFF J
Company: Notable Labs, Ltd.
Industry: Medical - Biomedical and Genetics
Company: Notable Labs, Ltd.
Industry: Medical - Biomedical and Genetics
Ofra-Vec Receives Fast Track; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: RAMAKANTH S
Company: Notable Labs, Ltd.
Industry: Medical - Biomedical and Genetics
VB-111 Fast Tracked in Ovarian Cancer, Hastening Regulatory Activities if Successful
Provider: Roth Capital Partners, Inc.
Analyst: ASCHOFF J
Company: Notable Labs, Ltd.
Industry: Medical - Biomedical and Genetics
Company: Notable Labs, Ltd.
Industry: Medical - Biomedical and Genetics
Company: Notable Labs, Ltd.
Industry: Medical - Biomedical and Genetics
Ovarian Cancer KOL Event - Prepared Remarks Mostly Known, Informative Q&A
Provider: Roth Capital Partners, Inc.
Analyst: ASCHOFF J